1. Cadet JL. Tardive Dyskinesia and Oxidative Stress. In: Connor JR, editor. Metals and Oxidative Damage in Neurological Disorders. New York (NY): Springer, 1997, p. 315-324.
2. Lohr JB, Kuczenski R, Niculescu AB. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 2003;17:47-62.
3. Lee HJ, Kang SG. Genetics of tardive dyskinesia. Int Rev Neurobiol 2011;98:231-264.
4. Korean Neuropsychiatric Association (Korea). Textbook of Neuropsychiatry 2nd Ed. Seoul: Jungang Moonhwa & Co.;; 2005.
5. Lee HJ, Cho CH. Oxidative stress and tardive dyskinesia: pharmacogenetic evidence. Prog Neuropsychopharmacol Biol Psychiatry 2013;46:207-213.
6. Moore KW, Malefyt RDW, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
7. Huet O, Laemmel E, Fu Y, Dupic L, Aprico A, Andrews KL, et al. Interleukin 10 antioxidant effect decreases leukocytes/endothelial interaction induced by tumor necrosis factor α. Shock 2013;39:83-88.
9. Wang M, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V, et al. Association of
IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate 2009;69:874-885.
10. So SJ, Kang SG, Lee HJ, Kim L. Association between tardive dyskinesia and polymorphisms of TNF-α gene in Korean schizophrenia patients. Korean J Schizophr Res 2013;16:38-42.
11. Son WY, Lee HJ, Yoon HK, Kang SG, Park YM, Yang HJ, et al. GABA transporter SLC6A11 gene polymorphism associated with tardive dyskinesia. Nord J Psychiatry 2014;68:123-128.
14. Lee HJ, Kang SG, Choi JE, Paik JW, Kim YK, Kim SH, et al. No association between dopamine D4 receptor gene-521 C/T polymorphism and tardive dyskinesia in schizophrenia. Neuropsychobiology 2007;55:47-51.
15. Lee HJ, Kang SG, Paik JW, Lee MS, Cho BH, Park YM, et al. No evidence for an association between G protein β3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia. Hum Psychopharmacol 2007;22:501-504.
16. Vossen RH, Aten E, Roos A, den Dunnen JT. High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 2009;30:860-866.
17. Capsoni F, Minonzio F, Ongari AM, Carbonellil V, Galli A, Zanussi C. Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils. Scand J Immunol 1997;45:269-275.